IL166270A0 - A pharmaceutical composition containing an activated form of ultra small doses of antibodies to the endothelial nitric acid synthase - Google Patents

A pharmaceutical composition containing an activated form of ultra small doses of antibodies to the endothelial nitric acid synthase

Info

Publication number
IL166270A0
IL166270A0 IL16627005A IL16627005A IL166270A0 IL 166270 A0 IL166270 A0 IL 166270A0 IL 16627005 A IL16627005 A IL 16627005A IL 16627005 A IL16627005 A IL 16627005A IL 166270 A0 IL166270 A0 IL 166270A0
Authority
IL
Israel
Prior art keywords
antibodies
pharmaceutical composition
composition containing
nitric acid
acid synthase
Prior art date
Application number
IL16627005A
Original Assignee
Evgeny Danilovich Goldberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evgeny Danilovich Goldberg filed Critical Evgeny Danilovich Goldberg
Publication of IL166270A0 publication Critical patent/IL166270A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16627005A 2002-08-02 2005-01-06 A pharmaceutical composition containing an activated form of ultra small doses of antibodies to the endothelial nitric acid synthase IL166270A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2002/000366 WO2004012765A1 (en) 2002-08-02 2002-08-02 Medicinal agent and method for curing pathological syndrome associated to hemodiscrasia

Publications (1)

Publication Number Publication Date
IL166270A0 true IL166270A0 (en) 2006-01-15

Family

ID=31492974

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16627005A IL166270A0 (en) 2002-08-02 2005-01-06 A pharmaceutical composition containing an activated form of ultra small doses of antibodies to the endothelial nitric acid synthase

Country Status (3)

Country Link
AU (1) AU2002325432A1 (en)
IL (1) IL166270A0 (en)
WO (1) WO2004012765A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
EP2395021A1 (en) 2006-06-06 2011-12-14 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2070338C1 (en) * 1992-03-03 1996-12-10 Сергей Владимирович Панько Method for transplanting bone marrow into the bone area under experimental conditions
PT691988E (en) * 1993-03-31 2003-02-28 Wellstat Therapeutics Corp INHIBITOR OF PROLIFERATION OF STELLIC CELLS AND THEIR UTILIZATIONS
US5885574A (en) * 1994-07-26 1999-03-23 Amgen Inc. Antibodies which activate an erythropoietin receptor
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent

Also Published As

Publication number Publication date
AU2002325432A1 (en) 2004-02-23
WO2004012765A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
IL166269A0 (en) A pharmaceutical composition containing an activated form of diluted antibodies to ?-tnf
IL166268A0 (en) A pharmaceutical comopsition containing an activated form of ultra small doses of antibodies to a prostate specific antigen
EP1712240A4 (en) Stable water-based medicinal preparation containing antibody
IL176749A0 (en) ANTIBODIES TO MAdCAM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL177869A0 (en) A stable pharmaceutical composition comprising an acid labile drug
IL245355A0 (en) Pharmaceutical composition containing a tetrahydrofolic acid
IL233925A0 (en) Anti-misuse microparticulate oral pharmaceutical form
AU2003299480A8 (en) Pharmaceutical composition including low dosages of desmopressin
IL153463A0 (en) Pharmaceutical compositions comprising activated antibodies
ZA200809998B (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
IL181689A0 (en) Aptamers to von willebrand factor and pharmaceutical compositions containing the same
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
IL172598A0 (en) Antibodies specific for sclerostin and pharmaceutical compositions containing the same
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL178294A0 (en) Thienopyridine derivatives and pharmaceutical compositions containing the same
IL183212A0 (en) Fused cyclic and heterocyclic compounds which bind to tubulin and pharmaceutical compositions containing the same
SI1752443T1 (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
IL178425A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
WO2006078659A8 (en) Stable prostaglandin-containing compositions
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
AU2003221604A8 (en) Use of an active substance that binds to cd28 for producing a pharmaceutical composition
EE200300537A (en) A process for the manufacture of a low dose pharmaceutical composition
EP1539156B8 (en) Liquid dosage forms of acid labile drugs
IL166270A0 (en) A pharmaceutical composition containing an activated form of ultra small doses of antibodies to the endothelial nitric acid synthase
EP1703904A4 (en) Taxoid-fatty acid conjugates and pharmaceutical compositions thereof